Northwest Medical Isotopes, LLC, 24289 [2015-10127]
Download as PDF
Federal Register / Vol. 80, No. 83 / Thursday, April 30, 2015 / Notices
prospective award nominees.
Additional survey areas may also
include:
• Applicant Mentoring
• Mentor Training
• State selection Committee
• State selection Process
• Applicant and State Finalist
Notification and Recognition
• In-kind contributions
The survey will evaluate the impact
SCs have on attracting prospective
award nominees to PAEMST. This will
be conducted as a Web-based survey.
Estimate of Burden: Public reporting
burden for this collection of information
is estimated to average 30–40 minutes
for State Coordinators.
Respondents: Individuals.
Estimated Number of Responses per
Form: 120 Coordinators.
Estimated Total Annual Burden on
Respondents: 80 hours (120
Coordinators at 40 minutes per survey =
80 hours).
Frequency of Response: One per
application cycle.
Comments: Comments are invited on
(a) whether the proposed collection of
information is necessary for the proper
performance of the PAEMST functions,
including whether the information shall
have practical utility; (b) the accuracy of
the NSF’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information on
respondents, including through the use
of automated collection techniques or
other forms of information technology;
(d) ways to minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical or other
technological collection techniques or
other forms of information technology.
Dated: April 27, 2015.
Suzanne H. Plimpton,
Reports Clearance Officer, National Science
Foundation.
[FR Doc. 2015–10074 Filed 4–29–15; 8:45 am]
BILLING CODE 7555–01–P
NUCLEAR REGULATORY
COMMISSION
mstockstill on DSK4VPTVN1PROD with NOTICES
[Proj–0803; NRC–2013–0235]
Northwest Medical Isotopes, LLC
Nuclear Regulatory
Commission.
ACTION: Construction permit
application; receipt.
AGENCY:
The U.S. Nuclear Regulatory
Commission (NRC) staff has received
SUMMARY:
VerDate Sep<11>2014
17:01 Apr 29, 2015
Jkt 235001
and is making available the first part of
the application for a construction
permit, submitted by Northwest Medical
Isotopes, LLC (NWMI). NWMI proposes
to build a medical radioisotope
production facility located in Columbia,
Missouri.
DATES: April 30, 2015.
ADDRESSES: Please refer to Docket ID
NRC–2013–0235 when contacting the
NRC about the availability of
information regarding this document.
You may obtain publicly-available
information related to this document
using any of the following methods:
• Federal Rulemaking Web site: Go to
https://www.regulations.gov and search
for Docket ID NRC–2013–0235. Address
questions about NRC dockets to Carol
Gallagher; telephone: 301–415–3463;
email: Carol.Gallagher@nrc.gov. For
technical questions, contact the
individual listed in the FOR FURTHER
INFORMATION CONTACT section of this
document.
• NRC’s Agencywide Documents
Access and Management System
(ADAMS): You may obtain publiclyavailable documents online in the
ADAMS Public Documents collection at
https://www.nrc.gov/reading-rm/
adams.html. To begin the search, select
‘‘ADAMS Public Documents’’ and then
select ‘‘Begin Web-based ADAMS
Search.’’ For problems with ADAMS,
please contact the NRC’s Public
Document Room (PDR) reference staff at
1–800–397–4209, 301–415–4737, or by
email to pdr.resource@nrc.gov. The
ADAMS accession number for each
document referenced (if it available in
ADAMS) is provided the first time that
a document is referenced.
• NRC’s PDR: You may examine and
purchase copies of public documents at
the NRC’s PDR, Room O1–F21, One
White Flint North, 11555 Rockville
Pike, Rockville, Maryland 20852.
FOR FURTHER INFORMATION CONTACT:
Michael Balazik, Office of Nuclear
Reactor Regulation, U.S. Nuclear
Regulatory Commission, Washington,
DC 20555–0001; telephone: 301–415–
2856; email: Michael.Balazik@nrc.gov.
SUPPLEMENTARY INFORMATION: On
November 7, 2014, NWMI filed with the
NRC, pursuant to Section 103 of the
Atomic Energy Act of 1954, as amended,
and part 50 of Title 10 of the Code of
Federal Regulations (10 CFR), a portion
of an application for a construction
permit for a medical radioisotope
production facility in Columbia,
Missouri. By letter dated February 5,
2015 (ADAMS Accession No.
ML15086A262), NWMI withdrew and
resubmitted this portion of their
construction permit application
PO 00000
Frm 00060
Fmt 4703
Sfmt 9990
24289
(ADAMS Accession No. ML15086A261)
to include a discussion of connected
actions in their environmental report in
response to a letter from the NRC
(ADAMS Accession No. ML14349A501).
An exemption from certain
requirements of 10 CFR 2.101(a)(5)
granted by the Commission on October
7, 2013 (ADAMS Accession No.
ML13238A333), in response to a letter
from NWMI dated August 9, 2013
(ADAMS Accession No. ML13227A295),
allowed for NWMI to submit its
construction permit application in two
parts. Specifically, the exemption
allowed NWMI to submit a portion of its
application for a construction permit up
to 6 months prior to the remainder of
the application regardless of whether or
not an environmental impact statement
or a supplement to an environmental
impact statement is prepared during the
review of its application. On February 5,
2015, in accordance with 10 CFR
2.101(a)(5), NWMI submitted the
following in part one of the construction
permit application:
• the description and safety
assessment of the site required by 10
CFR 50.34(a)(1),
• the environmental report required
by 10 CFR 50.30(f),
• the filing fee information required
by 10 CFR 50.30(e) and 10 CFR 170.21,
• the general information required by
10 CFR 50.33, and
• the agreement limiting access to
classified information required by 10
CFR 50.37.
As stated in NWMI’s February 5,
2015, letter, part two of NWMI’s
application for a construction permit
will contain the remainder of the
preliminary safety analysis report
required by 10 CFR 50.34(a) and will be
submitted in accordance with the
requirements of 10 CFR 2.101(a)(5).
Subsequent Federal Register notices
will address the acceptability of this
part of the tendered construction permit
application for docketing and provisions
for public participation in the
construction permit application review
process.
Dated at Rockville, Maryland, this 13th day
of April, 2015.
For the Nuclear Regulatory Commission.
Alexander Adams, Jr.,
Chief, Research and Test Reactors Licensing
Branch, Division of Policy and Rulemaking,
Office of Nuclear Reactor Regulation.
[FR Doc. 2015–10127 Filed 4–29–15; 8:45 am]
BILLING CODE 7590–01–P
E:\FR\FM\30APN1.SGM
30APN1
Agencies
[Federal Register Volume 80, Number 83 (Thursday, April 30, 2015)]
[Notices]
[Page 24289]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-10127]
=======================================================================
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
[Proj-0803; NRC-2013-0235]
Northwest Medical Isotopes, LLC
AGENCY: Nuclear Regulatory Commission.
ACTION: Construction permit application; receipt.
-----------------------------------------------------------------------
SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) staff has
received and is making available the first part of the application for
a construction permit, submitted by Northwest Medical Isotopes, LLC
(NWMI). NWMI proposes to build a medical radioisotope production
facility located in Columbia, Missouri.
DATES: April 30, 2015.
ADDRESSES: Please refer to Docket ID NRC-2013-0235 when contacting the
NRC about the availability of information regarding this document. You
may obtain publicly-available information related to this document
using any of the following methods:
Federal Rulemaking Web site: Go to https://www.regulations.gov and search for Docket ID NRC-2013-0235. Address
questions about NRC dockets to Carol Gallagher; telephone: 301-415-
3463; email: Carol.Gallagher@nrc.gov. For technical questions, contact
the individual listed in the FOR FURTHER INFORMATION CONTACT section of
this document.
NRC's Agencywide Documents Access and Management System
(ADAMS): You may obtain publicly-available documents online in the
ADAMS Public Documents collection at https://www.nrc.gov/reading-rm/adams.html. To begin the search, select ``ADAMS Public Documents'' and
then select ``Begin Web-based ADAMS Search.'' For problems with ADAMS,
please contact the NRC's Public Document Room (PDR) reference staff at
1-800-397-4209, 301-415-4737, or by email to pdr.resource@nrc.gov. The
ADAMS accession number for each document referenced (if it available in
ADAMS) is provided the first time that a document is referenced.
NRC's PDR: You may examine and purchase copies of public
documents at the NRC's PDR, Room O1-F21, One White Flint North, 11555
Rockville Pike, Rockville, Maryland 20852.
FOR FURTHER INFORMATION CONTACT: Michael Balazik, Office of Nuclear
Reactor Regulation, U.S. Nuclear Regulatory Commission, Washington, DC
20555-0001; telephone: 301-415-2856; email: Michael.Balazik@nrc.gov.
SUPPLEMENTARY INFORMATION: On November 7, 2014, NWMI filed with the
NRC, pursuant to Section 103 of the Atomic Energy Act of 1954, as
amended, and part 50 of Title 10 of the Code of Federal Regulations (10
CFR), a portion of an application for a construction permit for a
medical radioisotope production facility in Columbia, Missouri. By
letter dated February 5, 2015 (ADAMS Accession No. ML15086A262), NWMI
withdrew and resubmitted this portion of their construction permit
application (ADAMS Accession No. ML15086A261) to include a discussion
of connected actions in their environmental report in response to a
letter from the NRC (ADAMS Accession No. ML14349A501).
An exemption from certain requirements of 10 CFR 2.101(a)(5)
granted by the Commission on October 7, 2013 (ADAMS Accession No.
ML13238A333), in response to a letter from NWMI dated August 9, 2013
(ADAMS Accession No. ML13227A295), allowed for NWMI to submit its
construction permit application in two parts. Specifically, the
exemption allowed NWMI to submit a portion of its application for a
construction permit up to 6 months prior to the remainder of the
application regardless of whether or not an environmental impact
statement or a supplement to an environmental impact statement is
prepared during the review of its application. On February 5, 2015, in
accordance with 10 CFR 2.101(a)(5), NWMI submitted the following in
part one of the construction permit application:
the description and safety assessment of the site required
by 10 CFR 50.34(a)(1),
the environmental report required by 10 CFR 50.30(f),
the filing fee information required by 10 CFR 50.30(e) and
10 CFR 170.21,
the general information required by 10 CFR 50.33, and
the agreement limiting access to classified information
required by 10 CFR 50.37.
As stated in NWMI's February 5, 2015, letter, part two of NWMI's
application for a construction permit will contain the remainder of the
preliminary safety analysis report required by 10 CFR 50.34(a) and will
be submitted in accordance with the requirements of 10 CFR 2.101(a)(5).
Subsequent Federal Register notices will address the acceptability
of this part of the tendered construction permit application for
docketing and provisions for public participation in the construction
permit application review process.
Dated at Rockville, Maryland, this 13th day of April, 2015.
For the Nuclear Regulatory Commission.
Alexander Adams, Jr.,
Chief, Research and Test Reactors Licensing Branch, Division of Policy
and Rulemaking, Office of Nuclear Reactor Regulation.
[FR Doc. 2015-10127 Filed 4-29-15; 8:45 am]
BILLING CODE 7590-01-P